ArticleArthritis & rheumatology (Hoboken, N.J.)2025

Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022.

Priyanka Yalamanchili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.